WEREWOLF THERAPEUTICS INC (HOWL)

US95075A1079 - Common Stock

6.02  -0.22 (-3.53%)

After market: 6.33 +0.31 (+5.15%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
19.94M16.40M0.000.000.00
Operating Expenses
60.45M72.46M50.09M22.40M9.94M
Research and Development
41.78M53.76M35.27M16.64M6.34M
Selling, General, and Administrative Expenses
18.67M18.70M14.82M5.76M3.60M
Operating Income
-40.50M-56.06M-50.09M-22.40M-9.94M
Interest Income/Expense
4.28M1.91M100.00K100.00K-370.00K
Other Income/Expense
-1.14M340.00K0.007.26M60.00K
Income Before Taxes
-37.37M-53.81M-49.98M-15.04M-10.25M
Income Tax
N/AN/AN/A0.000.00
Net Income
-37.37M-53.81M-201.93M-28.22M-18.23M
EBITDA
-38.74M-54.96M-49.87M-22.25M-9.91M
 
Per Share Data
EPS Diluted Total Ops
-1.05-1.86-7.39-1.02-0.66
Non GAAP EPS
-1.04-1.88-88.35N/AN/A
 
Statistics
Profit Margin
-187.37%-328.11%N/AN/AN/A
Operating Profit Margin
-203.09%-341.83%N/AN/AN/A

All data in USD

Charts